PMID: 827398Nov 1, 1976Paper

Ehe diagnosis and treatment of thyrotoxicosis

Clinical Endocrinology
W J Irvine, A D Toft


No abstract listed.


Jan 23, 1975·The New England Journal of Medicine·A M SafaA Rodriguez-Antunez
Feb 15, 1975·Lancet·J G TurnerW A Sadler
Apr 26, 1975·Lancet·P MarsdenC G McKerron
Oct 4, 1975·Lancet
Dec 20, 1975·Lancet·P H WiseP E Harding
Jan 31, 1976·British Medical Journal·D C Evered
Mar 20, 1976·Lancet·J G TurnerT G Rogers
Jun 5, 1976·Lancet·G A BrayI J Chopra
Mar 27, 1976·Lancet·A BurgerL Braverman
Feb 20, 1975·The New England Journal of Medicine·J N Forrest
Feb 1, 1976·The American Journal of Digestive Diseases·L R Dragstedt
Mar 1, 1975·Clinical Endocrinology·A von zur MühlenJ Köbberling
Jul 1, 1975·The Journal of Clinical Endocrinology and Metabolism·L G KrugmanG N Chua Teco
Oct 2, 1975·The New England Journal of Medicine·A G VagenakisS H Ingbar
Nov 22, 1975·British Medical Journal·A W BurrowsC W Burke
Dec 1, 1976·The Journal of Clinical Endocrinology and Metabolism·A D ToftG P Lidgard
Feb 14, 1976·British Medical Journal·J C Stewart, G I Vidor
Jan 1, 1975·Metabolism: Clinical and Experimental·L P GeorgesJ J Canary
Jan 4, 1975·British Medical Journal·D EveredP H Dickinson
Sep 1, 1975·The Medical Clinics of North America·K Sterling
Mar 1, 1975·Clinical Endocrinology·P Marsden, C G McKerron
Jan 1, 1976·The Journal of Clinical Endocrinology and Metabolism·M C GershengornJ Robbins
May 3, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·J SethW J Irvine
Oct 29, 1970·The New England Journal of Medicine·A HayekJ D Crawford
Jul 3, 1971·Lancet·B J OrmstonR Hall
Jan 1, 1972·British Medical Journal·W MichieP D Bewsher
Jun 1, 1972·The Journal of Clinical Endocrinology and Metabolism·I J Chopra
Jun 1, 1972·Annals of Surgery·J L SawyersL Rosenfeld
Oct 1, 1972·The Journal of Clinical Investigation·R TempleJ Wolff
Oct 28, 1972·British Medical Journal· Hoff W van'tN M Eiser
Dec 16, 1972·Lancet·C S HollanderE Silva
Jan 6, 1973·British Medical Journal·V Ronnov-Jessen, C Kirkegaard
May 12, 1973·British Medical Journal·D G McLartyP Horton
Aug 11, 1973·Lancet·W F BremnerW R Greig

❮ Previous
Next ❯


Jan 1, 1982·European Journal of Clinical Pharmacology·A AroH Sundquist
Mar 1, 1978·Clinics in Endocrinology and Metabolism·L E Braverman
Apr 1, 1981·International Journal of Dermatology·J E Freitas
Jan 22, 1998·The American Journal of Physiology·F J DazaA Martín-Requero
Sep 15, 1986·The Medical Journal of Australia·J R Stockigt, D J Topliss

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.